Lan Lan is widely recognized as one of the leading lawyers in international corporate and insurance law, with an active practice advising some of the largest multinational financial and industrial groups in the world. Her practice focuses on multi-industry M&A transactions and advice on transactional and regulatory matters for financial service companies, especially insurance and asset management companies.
One of the foremost experts on insurance law and the insurance industry in China, Ms. Lan counts as her clients the most prestigious insurance companies in the world, whom she advises on every aspect of their investment and operations in China.
Ms. Lan has significant experience advising multinational clients on the structure of their presence in China through acquisitions or formation of green-field companies. Her clients benefit from her in-depth knowledge of the details and nuances of local PRC laws and regulations, as well as the policies and politics behind promulgated laws and regulations, which together form the regulatory and legal environment facing international companies in China.
Before joining JT&N, Lan Lan was the General Manager of John Hancock Life Insurance Company in China, overseeing its Beijing, Tianjin and Guangzhou representative offices. Prior to joining John Hancock, Ms. Lan practiced law in New York with Skadden, Arps, Slate, Meagher & Flom. She worked as a junior diplomat in the Ministry of Foreign Affairs of China before going to law school.
Ms. Lan's representative experience in the past 5 years includes:
Mergers and Acquisitions
· Advised Koenigsegg and SAAB in negotiations with Beijing Auto in connection with sale of equity and assets of SAAB;
· Advised one of the largest metal companies in the world in connection with its negotiation with PRC companies in the M&A area;
· Advised a major Asian industrial conglomerate in settling an M&A-related dispute involving more than Rmb900 million with a PRC provincial government and its controlled investment arm;
· T-Systems International GmbH in merging T-Systems China with gedas (Shanghai) Information Technology;
· One of the largest international private equity firms in its purchase of the Chinese operation of a major multinational medical appliance corporation;
· Lion Copolymer LLC. in its acquisition of the China operation of Chemtura Corporation;
· Hyosung Corporation in its acquisition of 100% of the equity of Nantong Transformer Co., Ltd. and Nantong Yaubong Transformer Co., Ltd.
· A major Asian corporation in its RMB 909 million purchase of an absolute majority stake in a State-owned heavy industry company and certain affiliated assets (including real property and equipment) through public bidding;
· A major international private equity firm in its issuance of convertible notes to a PRC insurance broker and agency concern;
· A major Asian corporation in acquiring a majority of the shares of a PRC State-owned company;
· A major Asian corporation in its USD 147 million purchase of the major assets of a privately owned company in Shandong Province;
· Mercer Consulting Co. in acquiring a stake in a local insurance brokerage company;
· CitiInsurance of Citigroup in assessing and negotiating with potential acquisition targets;
· A major US non-life company in selecting, assessing and negotiations with potential acquisition targets;
· A major Asian sovereign fund in acquiring minority stakes in PRC asset management companies.
· Advised a major multinational broker in acquiring the brokerage arm of an international financial conglomerate;
· Advised a multinational insurance group in communication with PRC regulators and successfully achieved Stage I insurance license in China;
· A German health company in forming its China strategy;
· A major Japanese financial group in its dispute resolution with the PRC insurance regulator;
· A major German re-insurance group in establishing its first branch in China and its on-going operations in China;
· A major US brokerage company in applying for a China green-field license;
· Insurance operation of a major global financial conglomerate on establishing a life operation in China;
· Lloyd's of London in establishing its wholly-owned reinsurance company in Shanghai, with on-going advice on PRC regulatory and legal issues in its China operations;
· CitiInsurance of Citigroup in negotiating its life joint venture and obtaining life insurance license in China;
· John Hancock Financial Services Inc. in obtaining its China license and negotiating its life insurance joint venture in China;
· A major U.S. property and casualty company in obtaining its China license, forming distribution alliances with local partners, selecting acquisition targets and on-going corporate compliance and legal matters in China;
· Samsung Life in forming its China strategy;
· Kyobo Life in forming its China strategy and establishing its China representative office;
· A major U.S. health company in establishing its China representative office;
· The direct marketing unit of a major European insurance conglomerate in establishing a new distribution channel in China.
· One of the largest US asset managers in negotiating investment management agreements with a major PRC institutional investor;
· A major global asset manager in drafting its private placement memorandum and its application to CSRC for QFII status;
· One of the largest US hedge funds in working with a major PRC QDII.